Compare $AURA vs $NVCT | Chartloom

Compare

$AURA vs $NVCT

Aura Biosciences Inc · Nuvectis Pharma Inc

AURA

Aura Biosciences Inc

NVCT

Nuvectis Pharma Inc

Compare $AURA vs $NVCT

Comparing Aura Biosciences Inc and Nuvectis Pharma Inc

AURAAura Biosciences Inc

NVCTNuvectis Pharma Inc

AURAAura Biosciences Inc

Market cap

$676M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

23.4%

52W performance

7.4%

FCF yield

-15.3%

NVCTNuvectis Pharma Inc

Market cap

$666M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

148.2%

52W performance

239.0%

FCF yield

-2.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AURA

NVCT

Detailed metrics comparison

AURA

Aura Biosciences Inc

NVCT

Nuvectis Pharma Inc

Market Cap

AURA$676M

NVCT$666M

Enterprise Value

AURA$609M

NVCT$644M

Price

AURA$6.54

NVCT$21.12

P/E Ratio

AURAN/A

NVCTN/A

P/S Ratio

AURA0.00x

NVCT0.00x

EV/Sales

AURA0.00x

NVCT0.00x

EV/EBITDA

AURA0.00x

NVCT0.00x

P/B Ratio

AURA2.00x

NVCT78.79x

P/FCF Ratio

AURAN/A

NVCTN/A

EV/FCF

AURA-5.89x

NVCT-33.00x

PEG Ratio

AURAN/A

NVCTN/A

Forward P/E (NTM)

AURAN/A

NVCTN/A

Forward P/S (NTM)

AURAN/A

NVCTN/A

Revenue (TTM)

AURA$0

NVCT$0

Revenue Growth (YoY)

AURAN/A

NVCTN/A

Forward Rev Growth

AURA591.6%

NVCT0.0%

Gross Margin (TTM)

AURA0.0%

NVCT0.0%

Operating Margin (TTM)

AURA0.0%

NVCT0.0%

EBITDA Margin (TTM)

AURA0.0%

NVCT0.0%

Net Margin (TTM)

AURA0.0%

NVCT0.0%

FCF Margin (TTM)

AURAN/A

NVCTN/A

Net Income (TTM)

AURA$-131M

NVCT$-30M

FCF (TTM)

AURA$-103M

NVCT$-20M

EPS (TTM)

AURA-$1.38

NVCT-$1.29

ROE (TTM)

AURA-7318.0%

NVCT-16947.0%

ROA (TTM)

AURA-6200.0%

NVCT-9680.0%

ROIC (TTM)

AURA-7318.0%

NVCT-16947.0%

Cash

AURA$68M

NVCT$22M

Debt

AURA$0

NVCT$0

Net Cash/Debt

AURA$68M

NVCT$22M

Current Ratio (TTM)

AURA16.82x

NVCT1.68x

Quick Ratio (TTM)

AURA16.69x

NVCT1.68x

Debt/Equity (TTM)

AURA0.00x

NVCT0.00x

Debt/Assets (TTM)

AURA0.0%

NVCT0.0%

Interest Coverage (TTM)

AURAN/A

NVCTN/A

Net Debt/EBITDA (TTM)

AURA0.00x

NVCT0.00x

Beta

AURA0.45

NVCT-0.23

52W Performance

AURA7.4%

NVCT239.0%

YTD Performance

AURA23.4%

NVCT148.2%

% from 52W High

AURA-31.4%

NVCT-27.9%

% from 52W Low

AURA38.3%

NVCT280.5%

Asset Turnover (TTM)

AURA0.00x

NVCT0.00x

FCF Yield (TTM)

AURA-15.3%

NVCT-2.9%

Earnings Yield (TTM)

AURA-19.4%

NVCT-4.5%

Dividend Yield (TTM)

AURAN/A

NVCTN/A

Rule of 40

AURA0.0

NVCT0.0

EV/GP/RG

AURAN/A

NVCTN/A

Ticker research

View AURA research View NVCT research

Metric	AURA Aura Biosciences Inc	NVCT Nuvectis Pharma Inc
Market & Valuation
Market Cap	$676M	$666M
Enterprise Value	$609M	$644M
Price	$6.54	$21.12
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.00x	78.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.89x	-33.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	591.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-131M	$-30M
FCF (TTM)	$-103M	$-20M
EPS (TTM)	-$1.38	-$1.29
ROE (TTM)	-7318.0%	-16947.0%
ROA (TTM)	-6200.0%	-9680.0%
ROIC (TTM)	-7318.0%	-16947.0%
Financial Health
Cash	$68M	$22M
Debt	$0	$0
Net Cash/Debt	$68M	$22M
Current Ratio (TTM)	16.82x	1.68x
Quick Ratio (TTM)	16.69x	1.68x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.45	-0.23
52W Performance	7.4%	239.0%
YTD Performance	23.4%	148.2%
% from 52W High	-31.4%	-27.9%
% from 52W Low	38.3%	280.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.3%	-2.9%
Earnings Yield (TTM)	-19.4%	-4.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AURA research	View NVCT research

Valuation

P/S Ratio

AURA

0.00x

NVCT

0.00x

EV/FCF

NVCT

-33.00x

AURA

-5.89x

Growth & revenue

Forward Revenue Growth

AURA

591.6%

NVCT

0.0%

Profitability & performance

Gross Margin

AURA

0.0%

NVCT

0.0%

ROE

AURA

-7318.0%

NVCT

-16947.0%

FCF Yield %

NVCT

-2.9%

AURA

-15.3%

52-Week Performance

NVCT

239.0%

AURA

7.4%

Detailed metrics comparison

AURA

Aura Biosciences Inc

NVCT

Nuvectis Pharma Inc

Market Cap

AURA$676M

NVCT$666M

Enterprise Value

AURA$609M

NVCT$644M

Price

AURA$6.54

NVCT$21.12

P/E Ratio

AURAN/A

NVCTN/A

P/S Ratio

AURA0.00x

NVCT0.00x

EV/Sales

AURA0.00x

NVCT0.00x

EV/EBITDA

AURA0.00x

NVCT0.00x

P/B Ratio

AURA2.00x

NVCT78.79x

P/FCF Ratio

AURAN/A

NVCTN/A

EV/FCF

AURA-5.89x

NVCT-33.00x

PEG Ratio

AURAN/A

NVCTN/A

Forward P/E (NTM)

AURAN/A

NVCTN/A

Forward P/S (NTM)

AURAN/A

NVCTN/A

Revenue (TTM)

AURA$0

NVCT$0

Revenue Growth (YoY)

AURAN/A

NVCTN/A

Forward Rev Growth

AURA591.6%

NVCT0.0%

Gross Margin (TTM)

AURA0.0%

NVCT0.0%

Operating Margin (TTM)

AURA0.0%

NVCT0.0%

EBITDA Margin (TTM)

AURA0.0%

NVCT0.0%

Net Margin (TTM)

AURA0.0%

NVCT0.0%

FCF Margin (TTM)

AURAN/A

NVCTN/A

Net Income (TTM)

AURA$-131M

NVCT$-30M

FCF (TTM)

AURA$-103M

NVCT$-20M

EPS (TTM)

AURA-$1.38

NVCT-$1.29

ROE (TTM)

AURA-7318.0%

NVCT-16947.0%

ROA (TTM)

AURA-6200.0%

NVCT-9680.0%

ROIC (TTM)

AURA-7318.0%

NVCT-16947.0%

Cash

AURA$68M

NVCT$22M

Debt

AURA$0

NVCT$0

Net Cash/Debt

AURA$68M

NVCT$22M

Current Ratio (TTM)

AURA16.82x

NVCT1.68x

Quick Ratio (TTM)

AURA16.69x

NVCT1.68x

Debt/Equity (TTM)

AURA0.00x

NVCT0.00x

Debt/Assets (TTM)

AURA0.0%

NVCT0.0%

Interest Coverage (TTM)

AURAN/A

NVCTN/A

Net Debt/EBITDA (TTM)

AURA0.00x

NVCT0.00x

Beta

AURA0.45

NVCT-0.23

52W Performance

AURA7.4%

NVCT239.0%

YTD Performance

AURA23.4%

NVCT148.2%

% from 52W High

AURA-31.4%

NVCT-27.9%

% from 52W Low

AURA38.3%

NVCT280.5%

Asset Turnover (TTM)

AURA0.00x

NVCT0.00x

FCF Yield (TTM)

AURA-15.3%

NVCT-2.9%

Earnings Yield (TTM)

AURA-19.4%

NVCT-4.5%

Dividend Yield (TTM)

AURAN/A

NVCTN/A

Rule of 40

AURA0.0

NVCT0.0

EV/GP/RG

AURAN/A

NVCTN/A

Ticker research

View AURA research View NVCT research

Metric	AURA Aura Biosciences Inc	NVCT Nuvectis Pharma Inc
Market & Valuation
Market Cap	$676M	$666M
Enterprise Value	$609M	$644M
Price	$6.54	$21.12
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.00x	78.79x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.89x	-33.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	591.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-131M	$-30M
FCF (TTM)	$-103M	$-20M
EPS (TTM)	-$1.38	-$1.29
ROE (TTM)	-7318.0%	-16947.0%
ROA (TTM)	-6200.0%	-9680.0%
ROIC (TTM)	-7318.0%	-16947.0%
Financial Health
Cash	$68M	$22M
Debt	$0	$0
Net Cash/Debt	$68M	$22M
Current Ratio (TTM)	16.82x	1.68x
Quick Ratio (TTM)	16.69x	1.68x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.45	-0.23
52W Performance	7.4%	239.0%
YTD Performance	23.4%	148.2%
% from 52W High	-31.4%	-27.9%
% from 52W Low	38.3%	280.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.3%	-2.9%
Earnings Yield (TTM)	-19.4%	-4.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AURA research	View NVCT research